Relationship Between Host Factors and the Incidence of Pulmonary Tuberculosis in HIV/AIDS Patients at Dr. Pirngadi Medan General Hospital
Abstract
Tuberculosis (TB) remains a major cause of morbidity and mortality among people living with HIV/AIDS. While CD4 count is a standard clinical indicator, inexpensive hematological indices such as the neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and systemic immune-inflammation index (SII) have been proposed as practical markers of immune status. This study examined the association between host factors (sociodemographics, CD4 count, and clinical stage) and hematological indices (NLR, MLR, and SII) with pulmonary TB among HIV/AIDS patients at Dr. Pirngadi Medan General Hospital. An analytical cross-sectional design with a retrospective approach was applied using secondary data from medical records of patients registered between 2022 and 2024. A total of 94 eligible patients were included through total sampling, and data were analyzed using the Chi-square test (p < 0.05). The pulmonary TB was identified in 43.6% of patients. CD4 count showed a significant association with TB occurrence (p = 0.03), with cases more frequent among patients with CD4 <200 cells/mm³. No significant associations were observed for age, sex, employment, marital status, clinical stage, or hematological indices (NLR, MLR, and SII) (p > 0.05). Thus, CD4 count remains the key predictor of pulmonary TB risk, underscoring the importance of intensified TB screening in individuals with advanced immunosuppression. Larger studies are warranted to clarify the potential role of hematological indices in TB-HIV coinfection.
Keywords: HIV/AIDS, Pulmonary Tuberculosis, CD4 Count, NLR, MLR, SII.
Full Text:
PDFReferences
Agizew, T., Boyd, R., Auld, A. F., Payton, L., Pals, S. L., Lekone, P., & Finlay, A. (2021). Tuberculosis comorbidities and predictors of mortality among people living with HIV. PLOS Global Public Health, 1(11), e0000030. https://doi.org/10.1371/journal.pgph.0000030
Albayrak, H. (2023). Neutrophil-to-Lymphocyte Ratio, Neutrophil-to-Monocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index in Psoriasis patients: response to treatment with biological drugs. Journal of Clinical Medicine, 12(17). https://doi.org/10.3390/jcm12175452
Choi, D., Im, H. Bin, Choi, S. J., & Han, D. (2024). Safety classification of herbal medicine use among hypertensive patients: a systematic review and meta-analysis. Frontiers in Pharmacology, 15(May), 1–22. https://doi.org/10.3389/fphar.2024.1321523
Dinkes Provinsi Sumatera Utara. (2023). Profil kesehatan Provinsi Sumatera Utara tahun 2023. Dinas Kesehatan Provinsi Sumatera Utara.
Dong, H., Feng, J., Chang, X., Wu, S., Tang, G., Liang, F., Tang, H., Dong, Y., Fang, W., Hu, J., & Wang, W. (2024). Predictive value of systemic immune-inflammatory biomarkers for drug-induced liver injury in hepatitis B virus surface antigen positive tuberculosis patients: A retrospective observational study. Medicine, 103(45), e40349. https://doi.org/10.1097/MD.0000000000040349
Fathiyah, R., Paramita, K., & Handayani, I. (2020). Analysis of Systemic Immune-Inflammation Index (SII) And CD4 count in HIV/AIDS patients with and without Tuberculosis co-infection. 298–302.
Gao, Y., Kuang, Y., Shen, C., & Chen, J. (2021). Systemic immune-inflammation index is associated with severity of pulmonary tuberculosis. Infection and Drug Resistance, 14, 2901-2910. https://doi.org/10.2147/IDR.S322306
Gesesew, H. A., Tsehaye, W. A., Carmody, J. C., Tolera, K. T., & Ward, P. (2021). TB-HIV coinfection and its determinants in Ethiopia: A systematic review and meta-analysis. PLoS One, 16(1), e0245237. https://doi.org/10.1371/journal.pone.0245237
Han, L., Liu, Y., Gao, Y., & Chen, J. (2022). Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio as predictors of survival in patients with HIV/AIDS. Medicine, 101(35), e30277. https://doi.org/10.1097/MD.0000000000030277
Imthiatiyyah, S. M., Deniati, E. N., Supriyadi, S., & Nurrochmah, S. (2025). Faktor sosiodemografi dan kejadian tuberkulosis di Indonesia berdasarkan IFLS 5. Holistik Jurnal Kesehatan, 19(3), 509–517. https://doi.org/10.33024/hjk.v19i3.906
Jiang, J., Huang, Y., Li, M., & Wang, Y. (2022). Prognostic value of the systemic immune-inflammation index in patients with pulmonary tuberculosis. Frontiers in Immunology, 13, 1024505. https://doi.org/10.3389/fimmu.2022.1024505
Kementerian Kesehatan Republik Indonesia. (2022). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Kementerian Kesehatan RI.
Li, Z., Wang, X., Wang, Y., & Chen, S. (2023). The predictive value of neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio for pulmonary tuberculosis. BMC Infectious Diseases, 23(1), 405. https://doi.org/10.1186/s12879-023-08381-z
Miyahara, R., Piyaworawong, S., Naranbhai, V., Prachamat, P., Kriengwatanapong, P., Tsuchiya, N., Wongyai, J., Bupachat, S., Yamada, N., Summanapan, S., Mahasirimongkol, S., & Yanai, H. (2019). Predicting the risk of pulmonary tuberculosis based on the neutrophil-to-lymphocyte ratio at TB screening in HIV-infected individuals. BMC Infectious Diseases, 19(1), 1–9. https://doi.org/10.1186/s12879-019-4292-9
Obeagu, E. I., & Obeagu, G. U. (2024). Utilization of immunological ratios in HIV: Implications for monitoring and therapeutic strategies. Medicine (United States), 103(9), E37354. https://doi.org/10.1097/MD.0000000000037354
Pranaya, A. Q., Hasan, H., & Bramantono, B. (2023). Profil Kadar Cd4 Pasien Hiv Koinfeksi Tb Paru Di Unit Perawatan Intermediet Penyakit Infeksi (Upipi) Rsud Dr. Soetomo Periode Januari €“ Desember 2019. Mitra Raflesia (Journal of Health Science), 15(2), 138–148. https://doi.org/10.51712/mitraraflesia.v15i2.327
Prasanna, P., Herrera, B., Schlesinger, L. S., Paiardini, M., & Sharan, R. (2025). Advances in host-directed therapy for tuberculosis and HIV coinfection: enhancing immune responses. Trends in Microbiology, xx(xx), 1–15. https://doi.org/10.1016/j.tim.2025.04.006
Puspitasari, R. D., Setiawan, B., & Santoso, P. (2021). Clinical characteristics and outcomes of TB-HIV coinfection patients in Indonesia. Tropical Medicine and Infectious Disease, 6(2), 70. https://doi.org/10.3390/tropicalmed6020070
Scully, E. P., & Bryson, B. D. (2021). Unlocking the complexity of HIV and Mycobacterium tuberculosis coinfection. Journal of Clinical Investigation, 131(22). https://doi.org/10.1172/JCI154407
Sulastri, N., Alisjahbana, B., Livia, R., & Sahiratmadja, E. (2021). Higher Neutrophil-lymphocyte Ratio in TB/HIV Co-infection Compared to Pulmonary Tuberculosis. Indonesian Biomedical Journal, 13(4), 375–382. https://doi.org/10.18585/INABJ.V13I4.1698
Tiberi, S., Du Plessis, N., Walzl, G., Vjecha, M. J., Rao, M., Ntoumi, F., Mfinanga, S., Kapata, N., Mwaba, P., McHugh, T. D., & Zumla, A. (2022). Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. The Lancet Infectious Diseases, 22(4), e108-e123. https://doi.org/10.1016/S1473-3099(21)00251-5
Wondim, A. A., Tesfaye, A., & Gebre, M. (2023). Tuberculosis prevalence and associated factors among HIV-positive adults. BMC Public Health, 23(1), 1012. https://doi.org/10.1186/s12889-023-15967-0
World Health Organization. (2023). Global tuberculosis report 2023. World Health Organization. https://www.who.int/publications/i/item/9789240083851
Yin, X., Zheng, Y., & Chen, J. (2021). Relationship between CD4+ T cell count and systemic immune-inflammation index in HIV/AIDS patients. Frontiers in Cellular and Infection Microbiology, 11, 712211. https://doi.org/10.3389/fcimb.2021.712211
Zhang, M., Zhao, P., & Li, Y. (2022). Diagnostic value of the neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio in tuberculosis: A meta-analysis. BMC Infectious Diseases, 22(1), 140. https://doi.org/10.1186/s12879-022-07122-y
DOI: http://dx.doi.org/10.30829/contagion.v8i1.26444
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Ali Napiah Nasution, Novianti Nasution, Yolanda Eliza Putra Lubis

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.




